Hospitalizations for Young-Onset Diabetes and the Impact of Mental Illness
Compared with patients who have onset type 2 diabetes at a usual age, adults with young-onset T2D are hospitalized significantly more often in their lifetimes.
Psychosis
Youths Who Use Marijuana Are at Increased Risk for Acute Psychotic Symptoms
Investigators examined whether adolescents who use marijuana heavily develop acute psychotic symptoms at a much higher rate than youths who use marijuana minimally or not at all.
Smoking Associated With Worsened Symptoms, Quality of Life in Patients With Psychosis
A negative association between number of cigarettes per day and quality of life was observed in patients with psychosis.
Potential Biomarker Differentiates Between Bipolar Disorder With, Without Psychosis
Altered glucose uptake in certain key regions in the brain may serve as a potential biomarker for key features in bipolar disorder.
Aberrant Epstein-Barr Virus Response Associated With Schizophrenia
Investigators confirmed that people with schizophrenia have higher levels of antibodies to some but not all Epstein-Barr virus proteins, which indicates an aberrant response to Epstein-Barr virus infection that may be a factor in the immunopathology of schizophrenia and related disorders.
Decreased EEG Beta/Low Gamma Oscillations in First-Episode Psychosis
Investigators examined the oscillatory activity of patients with first-episode psychosis after transcranial magnetic stimulation of the left motor cortex.
Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
Two studies indicate a link between cannabis use and mental health concerns, starting in adolescence and continuing into adulthood.
Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
British Study Shows Cannabis Use Adversely Affects Individuals With Early Psychosis
Experimental studies have shown that the primary psychoactive ingredient in cannabis can induce psychotic symptoms in otherwise healthy individuals.
Reducing Off-Label Quetiapine Prescribing the Old-Fashioned Way: Snail Mail
Despite the associated risk for death and cognitive decline, “off-label” prescribing of antipsychotics in patients with dementia has increased.
Next post in Neurocognitive Disorders
